Filter posts

Patient Storytelling: There’s an Art to it!

After 30-plus years working in Washington DC, it’s clear healthcare decision makers recognize that a …

#BIOSummit19 Concludes with Message of Hope Offered by Innovation

Representing all facets of the patient stakeholder community, participants in BIO’s eighth Patient and Health …

FDA Discusses Effective Patient Engagement at #BIOSummit19

For the FDA, engagement with patients, caregivers and patient advocacy organizations is a vital part …

#BIOSummit19: Education and Partnerships Raise Awareness

When Mark Dant’s son Ryan was first diagnosed with MPS-I, a rare genetic disorder that …

Fundraising Companies Find Strategic Partners that Best Fit Their Stage of Development at BIO Invest...

Since its inception 17 years ago, the BIO Investor Forum has become the premier event …

IPOs Are a Gateway to More Diverse Biotech Boards

As more biotechnology executives begin to focus on strategies to diversify their boards to avoid …

Investment Crackdown Prompts Chinese Investors to Leave U.S. Biotech Market and Focus on Europe

Confusion among Chinese investors about shifting U.S. regulatory policy is draining billions of dollars from …

Gene Therapies: The Pipeline Towards a New Era for Patients

On Tuesday morning at the BIO Investor Forum, leaders from top companies at the forefront of …

New BIO One-on-One Partnering Mobile App

BIO has released a new and improved mobile app for the BIO One-on-One Partnering™ system. …

Making Alzheimer’s Treatments a Priority

Alzheimer’s is one of the most feared diseases in the world. Despite many attempts to find …